biomodal: Investigating the role of the 6-base genome within the field of Cancer Research with a focus on breast and prostate cancer

This session, sponsored by biomodal, will encompass 2 talks investigating the role of the 6-base genome within the field of Cancer Research with a focus on breast and prostate cancer.   Topics will be ctDNA as a biomarker for early Prostate Cancer detection & the characterisation of advanced breast cancer subtypes in cfDNA by methylation profiling.   biomodal is an omics-based life sciences technology and analytics company delivering products that bring our ever-changing dynamic biology into focus. Our duet multiomics solution enables more information from a single, low input DNA sample without complex, resource intensive bioinformatics or harsh chemical treatment.